Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus

Proceedings of the Nutrition Society

Volumn 63, Issue 2, 2004, Pages 323-330

  Blaak, E E ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Fatty acid metabolism; Obesity; Skeletal muscle; Type 2 diabetes

Indexed keywords

BETA ADRENERGIC RECEPTOR; TRIACYLGLYCEROL;

ADIPOSE TISSUE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; EXERCISE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SKELETAL MUSCLE; WEIGHT REDUCTION;

DIABETES MELLITUS, TYPE 2; FATTY ACIDS; HUMANS; INSULIN RESISTANCE; LIPOLYSIS; MUSCLE, SKELETAL; OBESITY;

EID: 2942722772     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS2004361     Document Type: Conference Paper

References (54)

1. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, et al. (1999) Identification of Cd36 (fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nature Genetics 21, 76-83.
2. Blaak EE, van Aggel-Leijssen DP, Wagenmakers AJ, Saris WH & van Baak MA (2000a) Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes 49, 2102-2107.
3. Blaak EE, Van Baak MA, Kemerink GJ, Pakbiers MT, Heidendal GA & Saris WH (1994) beta-Adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men. American Journal of Physiology 267, E316-E322.
4. Blaak EE & Wagenmakers AJ (2002) The fate of [U-(13)C] palmitate extracted by skeletal muscle in subjects with type 2 diabetes and control subjects. Diabetes 51, 784-789.
5. Blaak EE, Wagenmakers AJ, Glatz JF, Wolffenbuttel BH, Kemerink GJ, Langenberg CJ, Heidendal GA & Saris WH (2000b) Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. American Journal of Physiology 279, E146-E154.
6. Blaak EE, Wolffenbuttel BH, Saris WH, Pelsers MM & Wagenmakers AJ (2001) Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects. Journal of Clinical Endocrinology and Metabolism 86, 1638-1644.
7. Boden G, Lebed B, Schatz M, Homko C & Lemieux S (2001) Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50, 1612-1617.
8. Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL & Abumrad NA (2000) Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knock-out mice. Journal of Biological Chemistry 275, 32523-32529.
9. Colberg SR, Simoneau JA, Thaete FL & Kelley DE (1995) Skeletal muscle utilization of free fatty acids in women with visceral obesity. Journal of Clinical Investigation 95, 1846-1853.
10. Dagenais GR, Tancredi RG & Zierler KL (1976) Free fatty acid oxidation by forearm muscle at rest, and evidence for an intramuscular lipid pool in the human forearm. Journal of Clinical Investigation 58, 421-431.
11. Ezell DM, Geiselman PJ, Anderson AM, Dowdy ML, Womble LG, Greenway FL & Zachwieja JJ (1999) Substrate oxidation and availability during acute exercise in non-obese, obese, and post-obese sedentary females. International Journal of Obesity and Related Metabolic Disorders 23, 1047-1056.
12. Froidevaux F, Schutz Y, Christin L & Jequier E (1993) Energy expenditure in obese women before and during weight loss, after refeeding, and in the weight-relapse period. American Journal of Clinical Nutrition 57, 35-42.
13. Geerling BJ, Alles MS, Murgatroyd PR, Goldberg GR, Harding M & Prentice AM (1994) Fatness in relation to substrate oxidation during exercise. International Journal of Obesity and Related Metabolic Disorders 18, 453-459.
14. Glatz JF, Luiken JJ & Bonen A (2001a) Involvement of membrane-associated proteins in the acute regulation of cellular fatty acid uptake. Journal of Molecular Neuroscience 16, 123-132.
15. Glatz JF, Luiken JJ & Bonen A (2001b) Involvement of membrane-associated proteins in the acute regulation of cellular fatty acid uptake: discussion. Journal of Molecular Neuroscience 16, 151-157.
16. Glatz JF, Schaap FG, Binas B, Bonen A, van der Vusse GJ & Luiken JJ (2003) Cytoplasmic fatty acid-binding protein facilitates fatty acid utilization by skeletal muscle. Acta Physiologica Scandinavica 178, 367-371.
17. Hagstrom-Toft E, Thorne A, Reynisdottir S, Moberg E, Rossner S, Bolinder J & Amer P (2001) Evidence for a major role of skeletal muscle lipolysis in the regulation of lipid oxidation during caloric restriction in vivo. Diabetes 50, 1604-1611.
18. Hajri T, Ibrahimi A, Coburn CT, Knapp FF Jr, Kurtz T, Pravenec M & Abumrad NA (2001) Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. Journal of Biological Chemistry 276, 23661-23666.
19. Helge JW, Fraser AM, Kriketos AD, Jenkins AB, Calvert GD, Ayre KJ & Storlien LH (1999) Interrelationships between muscle fibre type, substrate oxidation and body fat. International Journal of Obesity and Related Metabolic Disorders 23, 986-991.
20. Horowitz JF & Klein S (2000) Oxidation of nonplasma fatty acids during exercise is increased in women with abdominal obesity. Journal of Applied Physiology 89, 2276-2282.
21. Hulver MW, Berggren JR, Cortright RN, Dudek RW, Thompson RP, Pories WJ, MacDonald KG, Cline GW, Shulman GI, Dohm GL & Houmard JA (2003) Skeletal muscle lipid metabolism with obesity. American Journal of Physiology 284, E741-E747.
22. Jong-Yeon K, Hickner RC, Dohm GL & Houmard JA (2002) Long- and medium-chain fatty acid oxidation is increased in exercise-trained human skeletal muscle. Metabolism 51, 460-464.
23. Kelley DE & Goodpaster BH (2001) Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 24, 933-941.
24. Kelley DE, Goodpaster B, Wing RR & Simoneau JA (1999) Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. American Journal of Physiology 277, E1130-E1141.
25. Kelley DE & Mandarino LJ (2000) Fuel selection in human skeletal muscle in insulin resistance: a re-examination. Diabetes 49, 677-683.
26. Kelley DE & Simoneau JA (1994) Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation 94, 2349-2356.
27. Kim JY, Hickner RC, Cortright RL, Dohm GL & Houmard JA (2000) Lipid oxidation is reduced in obese human skeletal muscle. American Journal of Physiology 279, E1039-E1044.
28. Langfort J, Ploug T, Ihlemann J, Enevoldsen LH, Stallknecht B, Saldo M, Kjaer M, Holm C & Galbo H (1998) Hormone-sensitive lipase (HSL) expression and regulation in skeletal muscle. Advances in Experimental Medicine and Biology 441, 219-228.
29. Langfort J, Ploug T, Ihlemann J, Saldo M, Holm C & Galbo H (1999) Expression of hormone-sensitive lipase and its regulation by adrenaline in skeletal muscle. Biochemical Journal 340, 459-465.
30. Luiken JJ, Arumugam Y, Bell RC, Calles-Escandon J, Tandon NN, Glatz JF & Bonen A (2002a) Changes in fatty acid transport and transporters are related to the severity of insulin deficiency. American Journal of Physiology 283, E612-E621.
31. Luiken JJ, Arumugam Y, Dyck DJ, Bell RC, Pelsers MM, Turcotte LP, Tandon NN, Glatz JF & Bonen A (2001) Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. Journal of Biological Chemistry 276, 40567-40573.
32. Luiken JJ, Coort SL, Willems J, Coumans WA, Bonen A, van der Vusse GJ & Glatz JF (2003) Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 52, 1627-1634.
33. Luiken JJ, Dyck DJ, Han XX, Tandon NN, Arumugam Y, Glatz JF & Bonen A (2002b) Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane. American Journal of Physiology 282, E491-E495.
34. Mandarino LJ, Consoli A, Jain A & Kelley DE (1996) Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. American Journal of Physiology 270, E463-E470.
35. Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ & Saris WH (2001) Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 Diabetes. Diabetes 50, 2548-2554.
36. Mensink M, Blaak EE, Vidal H, De Bruin TW, Glatz JF & Saris WH (2003a) Lifestyle changes and lipid metabolism gene expression and protein content in skeletal muscle of subjects with impaired glucose tolerance. Diabetologia 46, 1082-1089.
37. Mensink M, Corpeleijn E, Feskens EJ, Kruijshoop M, Saris WH, de Bruin TW & Blaak EE (2003b) Study on lifestyle-intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results. Diabetes Research and Clinical Practice 61, 49-58.
38. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB & Storlien LH (1997) Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46, 983-988.
39. Randle PJ (1998) Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes/Metabolism Reviews 14, 263-283.
40. Ranneries C, Bulow J, Buemann B, Christensen NJ, Madsen J & Astrup A (1998) Fat metabolism in formerly obese women. American Journal of Physiology 274, E155-E161.
41. Rasmussen BB, Holmback UC, Volpi E, Morio-Liondore B, Paddon-Jones D & Wolfe RR (2002) Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle. Journal of Clinical Investigation 110, 1687-1693.
42. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW & Shulman GI (1996) Mechanism of free fatty acid-induced insulin resistance in humans. Journal of Clinical Investigation 97, 2859-2865.
43. Saha AK, Vavvas D, Kurowski TG, Apazidis A, Witters LA, Shafrir E & Ruderman NB (1997) Malonyl-CoA regulation in skeletal muscle: its link to cell citrate and the glucose-fatty acid cycle. American Journal of Physiology 272, E641-E648.
44. Schrauwen P, van Aggel-Leijssen DP, Hul G, Wagenmakers AJ, Vidal H, Saris WH & van Baak MA (2002) The effect of a 3-month low-intensity endurance training program on fat oxidation and acetyl-CoA carboxylase-2 expression. Diabetes 51, 2220-2226.
45. Sidossis LS & Wolfe RR (1996) Glucose and insulin-induced inhibition of fatty acid oxidation; the glucose-fatty acid cycle reversed. American Journal of Physiology 270, E733-E738.
46. Simoneau JA, Veerkamp JH, Turcotte LP & Kelley DE (1999) Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB Journal 13, 2051-2060.
47. Stumvoll M, Jacob S, Wahl HG, Hauer B, Loblein K, Grauer P, Becker R, Nielsen M, Renn W & Haring H (2000) Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in humans. Journal of Clinical Endocrinology and Metabolism 85, 3740-3745.
48. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V & Uusitupa M (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine 344, 1343-1350.
49. Turpeinen AK, Takala TO, Nuutila P, Axelin T, Luotolahti M, Haaparanta M, Bergman J, Hamalainen H, Iida H, Maki M, Uusitupa MI & Knuuti J (1999) Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Diabetes 48, 1245-1250.
50. van der Vusse GJ, van Bilsen M, Glatz JF, Hasselbaink DM & Luiken JJ (2002) Critical steps in cellular fatty acid uptake and utilization. Molecular and Cellular Biochemistry 239, 9-15.
51. Wade AJ, Marbut MM & Round JM (1990) Muscle fibre type and aetiology of obesity. Lancet 335, 805-808.
52. Watt MJ, Stellingwerff T, Heigenhauser GJ & Spriet LL (2003) Effects of plasma adrenaline on hormone-sensitive lipase at rest and during moderate exercise in human skeletal muscle. Journal of Physiology 550, 325-332.
53. Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR & Henry RR (2003) Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects. American Journal of Physiology 285, E354-E362.
54. Zurlo F, Lillioja S, Esposito-Del Puente A, Nyomba BL, Raz I, Saad MF, Swinburn BA, Knowler WC, Bogardus C & Ravussin E (1990) Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. American Journal of Physiology 259, E650-E657.